Plasma troponin levels after cardiac surgery vs after myocardial infarction

Dan Abramov1, Muhammad Abu-Tailakh, Michael Frieger

  • 1Department of Cardiothoracic Surgery, Soroka Medical Center, Beer Sheva 84101, Israel. abramov2@zahav.net.il

Insights

Postoperative troponin elevation differs from myocardial infarction. Cardiac surgery involves enhanced cell permeability and impaired troponin removal, unlike permanent damage seen in myocardial infarction.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Elevated plasma troponin is a key indicator of myocardial infarction.
  • Postoperative troponin elevation after cardiac surgery complicates diagnosis.
  • Understanding troponin kinetics is crucial for accurate diagnosis.

Purpose of the Study:

  • To compare troponin elimination curves after cardiac surgery, myocardial infarction, and myocardial infarction with reperfusion.
  • To investigate the mechanisms behind troponin elevation in these conditions.
  • To determine if post-myocardial infarction troponin data can be applied to post-cardiac surgery patients.

Main Methods:

  • Literature search for plasma troponin elimination curves.
  • Analysis of 11 curves from 70 studies using the Stratus immunoassay kit.
  • Formulation of new plots from mean troponin levels at time intervals for each group.

Main Results:

  • Cardiac surgery troponin up-slope was steeper than myocardial infarction, similar to myocardial infarction with reperfusion.
  • The down-slope of the cardiac surgery curve was significantly gentler than both other groups (-0.91 vs -5.31, p < 0.01).
  • This suggests enhanced cell permeability and potentially impaired troponin clearance post-surgery.

Conclusions:

  • Postoperative troponin elevation mechanisms differ from myocardial infarction.
  • Enhanced cell permeability and impaired troponin removal are suggested post-cardiac surgery.
  • Findings indicate that troponin level implications from myocardial infarction may not apply to post-cardiac surgery patients.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...